ConductScience.org, home

Paper11905830

Strategies for designing and optimizing new generation vaccines.

Berzofsky JA and 2 others. Nat Rev Immunol, 2001. Cited by 263 papers, by iCite.

Cite this record

ConductScience Library. Strategies for designing and optimizing new generation vaccines. Papers, record 11905830. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/11905830

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Strategies for designing and optimizing new generation vaccines.
PubMed
Journal
Nat Rev Immunol
PubMed
Year
2001
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
263
iCite
Relative citation ratio, by iCite
5.04
iCite
Revised in PubMed
2026-10-09
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Berzofsky JAJ A
2Ahlers JDJ D
3Belyakov IMI M

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
VaccinesMajor topic
Adjuvants, Immunologic
Animals
Cytokines
Dendritic Cells
Drug Design
Epitopes
Humans
Immunity, Mucosal
Models, Immunological
T-Lymphocytes, Cytotoxic
Vaccines, DNA

Source PubMed

Download CSV of topics

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT00972309A Pilot Study of Vaccination With Epitope-Enhanced TARP Peptide and TARP Peptide-Pulsed Dendritic Cells in the Treatment of Stage D0 Prostate CancerBackground

Source ClinicalTrials.gov

Download CSV of trials

References171

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
110727437Dendritic cells: at the clinical crossroads.J Clin Invest2000https://conductscience.org/library/papers/10727437PubMed
211313372Defined flanking spacers and enhanced proteolysis is essential for eradication of established tumors by an epitope string DNA vaccine.J Immunol2001https://conductscience.org/library/papers/11313372PubMed
38551248Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines.J Exp Med1996https://conductscience.org/library/papers/8551248PubMed
411733563High-affinity T helper epitope induces complementary helper and APC polarization, increased CTL, and protection against viral infection.J Clin Invest2001https://conductscience.org/library/papers/11733563PubMed
510099122Mucosal immune system of the human genital tract.J Infect Dis1999https://conductscience.org/library/papers/10099122PubMed
69632982The gastrointestinal tract and the pathogenesis of AIDS.AIDS1998https://conductscience.org/library/papers/9632982PubMed
711313385Prime-boost immunization with DNA vaccine: mucosal route of administration changes the rules.J Immunol2001https://conductscience.org/library/papers/11313385PubMed
88104103Prominent role of secondary anchor residues in peptide binding to HLA-A2.1 molecules.Cell1993https://conductscience.org/library/papers/8104103PubMed
99774275Induction of antigen-specific cytotoxic T lymphocytes in humans by a malaria DNA vaccine.Science1998https://conductscience.org/library/papers/9774275PubMed
101545867Genetic immunization is a simple method for eliciting an immune response.Nature1992https://conductscience.org/library/papers/1545867PubMed
1111325845Enhanced activation of human T cells via avipox vector-mediated hyperexpression of a triad of costimulatory molecules in human dendritic cells.Cancer Res2001https://conductscience.org/library/papers/11325845PubMed
129234241Priming of cytotoxic T lymphocytes by DNA vaccines: requirement for professional antigen presenting cells and evidence for antigen transfer from myocytes.Mol Med1997https://conductscience.org/library/papers/9234241PubMed
139541605Modulation of amplitude and direction of in vivo immune responses by co-administration of cytokine gene expression cassettes with DNA immunogens.Eur J Immunol1998https://conductscience.org/library/papers/9541605PubMed
147566090Induction of apoptosis in mature T cells by tumour necrosis factor.Nature1995https://conductscience.org/library/papers/7566090PubMed
158665591
Dendritic cells in antitumor immune responses. II. Dendritic cells grown from bone marrow precursors, but not mature DC from tumor-bearing mice, are effective antigen carriers in the therapy of established tumors.
Cell Immunol1996https://conductscience.org/library/papers/8665591PubMed
168097319Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity.Proc Natl Acad Sci U S A1993https://conductscience.org/library/papers/8097319PubMed
1710837079DNA vaccines: immunology, application, and optimization*.Annu Rev Immunol2000https://conductscience.org/library/papers/10837079PubMed
1811208869Differentiation of T regulatory cells by immature dendritic cells.J Exp Med2001https://conductscience.org/library/papers/11208869PubMed
1911238120Enhanced immune activity of cytotoxic T-lymphocyte epitope analogs derived from positional scanning synthetic combinatorial libraries.Blood2001https://conductscience.org/library/papers/11238120PubMed
2011257389Mucosal vaccines: non toxic derivatives of LT and CT as mucosal adjuvants.Vaccine2001https://conductscience.org/library/papers/11257389PubMed

See all 171 referencesDownload CSV of references

Cited by99

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 263 citations.

PMIDTitleJournalYearIn PapersSource
41736107Programmable trivalent nanocage vaccine confers durable cross-species protection against Bordetella bronchiseptica infection.J Nanobiotechnology2026https://conductscience.org/library/papers/41736107PubMed
40872750Primary Sequence-Intrinsic Immune Evasion by Viral Proteins Guides CTL-Based Vaccine Strategies.Viruses2025https://conductscience.org/library/papers/40872750PubMed
40733673ISG15 as a Potent Immune Adjuvant in MVA-Based Vaccines Against Zika Virus and SARS-CoV-2.Vaccines (Basel)2025https://conductscience.org/library/papers/40733673PubMed
40213668Designing multifunctional recombinant vaccines: an engineering strategy based on innovative epitope prediction-guided splicing.Theranostics2025https://conductscience.org/library/papers/40213668PubMed
39275069Self-Assembled Ferritin Nanoparticles for Delivery of Antigens and Development of Vaccines: From Structure and Property to Applications.Molecules2024https://conductscience.org/library/papers/39275069PubMed
38140232Challenges and Opportunities in the Process Development of Chimeric Vaccines.Vaccines (Basel)2023https://conductscience.org/library/papers/38140232PubMed
37768503Peptide-Based Therapeutics in Cancer Therapy.Mol Biotechnol2024https://conductscience.org/library/papers/37768503PubMed
35550001Recent trends in next generation immunoinformatics harnessed for universal coronavirus vaccine design.Pathog Glob Health2023https://conductscience.org/library/papers/35550001PubMed
34451945Using Adjuvants to Drive T Cell Responses for Next-Generation Infectious Disease Vaccines.Vaccines (Basel)2021https://conductscience.org/library/papers/34451945PubMed
32961248Promotion of CTL epitope presentation by a nanoparticle with environment-responsive stability and phagolysosomal escape capacity.J Control Release2020https://conductscience.org/library/papers/32961248PubMed
31969886High Peptide Dose Vaccination Promotes the Early Selection of Tumor Antigen-Specific CD8 T-Cells of Enhanced Functional Competence.Front Immunol2019https://conductscience.org/library/papers/31969886PubMed
31457034Immunogenicity of the Multi-Epitopic Recombinant Glycoproteins of Newcastle Disease Virus: Implications for the Serodiagnosis Applications.Iran J Biotechnol2018https://conductscience.org/library/papers/31457034PubMed
30873164Immunogenicity and Protective Efficacy of T-Cell Epitopes Derived From Potential Th1 Stimulatory Proteins of Leishmania (Leishmania) donovani.Front Immunol2019https://conductscience.org/library/papers/30873164PubMed
30524907Trial watch: Peptide-based vaccines in anticancer therapy.Oncoimmunology2018https://conductscience.org/library/papers/30524907PubMed
30019620An engineered novel lentivector specifically transducing dendritic cells and eliciting robust HBV-specific CTL response by upregulating autophagy in T cells.Cell Cycle2018https://conductscience.org/library/papers/30019620PubMed
29290804An Albumin-binding Polypeptide Both Targets Cytotoxic T Lymphocyte Vaccines to Lymph Nodes and Boosts Vaccine Presentation by Dendritic Cells.Theranostics2018https://conductscience.org/library/papers/29290804PubMed
29231862Conserved Binding Regions Provide the Clue for Peptide-Based Vaccine Development: A Chemical Perspective.Molecules2017https://conductscience.org/library/papers/29231862PubMed
29143114Cancer vaccine strategies: translation from mice to human clinical trials.Cancer Immunol Immunother2018https://conductscience.org/library/papers/29143114PubMed
28644608Targeting CpG Adjuvant to Lymph Node via Dextran Conjugate Enhances Antitumor Immunotherapy.Bioconjug Chem2017https://conductscience.org/library/papers/28644608PubMed
28432083Optimal CD4 T cell priming after LPS-based adjuvanticity with CD134 costimulation relies on CXCL9 production.J Leukoc Biol2017https://conductscience.org/library/papers/28432083PubMed

See all 99 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/11905830

GET https://conductscience.org/api/papers/v1/11905830/references?page=2